Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Cash flows from operating activities:
Net earnings (loss)	$ (19,071,000)	$ (5,067,000)	$ 5,170,000
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization expense	10,956,000	9,568,000	9,475,000
Net (gain) loss on disposition of assets	18,000	36,000	(5,570,000)
Net (gain) loss on derivatives and convertible debt	6,331,000	1,071,000	(317,000)
Equity in earnings of joint venture	(80,000)	(190,000)	218,000
Distributions from cumulative earnings of joint venture		170,000	187,000
Amortization of deferred financing costs	1,210,000	1,267,000	1,443,000
Impairment recovery, net	0	0	(93,000)
Stock-based compensation expense	173,000	1,026,000	974,000
Provision for deferred taxes	(421,000)	821,000	260,000
Changes in operating assets and liabilities:
Decrease in assets	531,000	1,172,000	582,000
Decrease in liabilities	(449,000)	(622,000)	(1,665,000)
Net cash provided by (used in) operating activities	(802,000)	9,252,000	10,664,000
Cash flows from investing activities:
Additions to hotel properties	(605,000)	(1,475,000)	(1,982,000)
Distributions in excess of cumulative earnings from joint venture	480,000	1,643,000	1,475,000
Hotel acquisitions	(7,193,000)		(35,643,000)
Net proceeds from sale of hotel assets	4,000	4,191,000	19,696,000
Net cash provided by (used in) investing activities	(7,314,000)	4,359,000	(16,454,000)
Cash flows from financing activities:
Deferred financing costs	(1,660,000)	(415,000)	(147,000)
Proceeds from long-term debt	47,264,000	1,500,000	35,318,000
Principal payments on long-term debt	(48,369,000)	(5,281,000)	(20,265,000)
Proceeds from common stock issuance			260,000
Proceeds from convertible debt	10,000,000
Redemption of common units		(42,000)	(298,000)
Tax withholdings on stock compensation	(30,000)	(356,000)	(205,000)
Cash dividends paid to common shareholders		(9,304,000)	(9,257,000)
Cash dividends paid to common unit holders		(36,000)	(72,000)
Cash dividends paid to preferred shareholders		(434,000)	(723,000)
Other items	(4,000)	(4,000)
Net cash provided by (used in) financing activities	7,201,000	(14,372,000)	4,611,000
Decrease in cash, cash equivalents, and restricted cash	(915,000)	(761,000)	(1,179,000)
Cash, cash equivalents, and restricted cash beginning of year	8,395,000	9,156,000	10,335,000
Cash, cash equivalents, and restricted cash end of year	7,480,000	8,395,000	9,156,000
Supplemental cash flow information:
Interest paid	7,272,000	6,732,000	6,091,000
Income taxes paid	119,000	307,000	42,000
Schedule of noncash investing and financing activities:
Debt assumed in acquisition	34,080,000
Increase in accrued liabilities related to insurance premium financing agreement	207,000	22,000	56,000
Land option liability in acquisition	$ 8,497,000
Fair value of operating partnership common units issued in acquisitions			$ 50,000
Fair value of operating partnership common units converted to common stock		$ 595,000